The main pharmaco-therapeutic effects of drugs: the reconnaissance has parasympatykolitychnu effect Sexually Transmitted Infection to the effect of atropine, in addition, quickly and briefly extends the pupil and paralyze accommodation effectively; tropikamidu mechanism of action is relatively competitive antagonism of acetylcholine, causing paralysis of the pupil sphincter and ciliary m ' yaza, Outside Hospital in increased pupil come and cycloplegia. Method of production of drugs: krap.och. Contraindications: suspected glaucoma, glaucoma, hypersensitivity to reconnaissance drug and its components. in the conjunctival sac of the affected eye (eyes) 2 g / day in some patients may achieve better results with instilling an Crapo. 1% of the district reconnaissance 5-minute period of time, research should reconnaissance carried out within 25-50 minutes of the last of reconnaissance drug, to study the retina sufficiently to enter two Crapo. S01FA04 - midriatychni and cycloplegic agents. 0,5%, 1% vial reconnaissance . every 3-4 hours. Indications for use drugs: reducing elevated intraocular pressure in hypertension and eye vidkrytokutoviy glaucoma as monotherapy for patients insensitive to beta-blockers, or patients that beta-blockers are contra-indicated, or as additional therapy when using beta-blockers. Side effects and complications in the use of drugs: misting vision, discomfort in the eyes (temporary heartburn or tingling after zakapyvaniya), foreign body sensation and reconnaissance hyperemia; rarely - dry eye, eye pain, discharge from eyes, itching, keratitis, blepharitis, conjunctivitis, kirochky formation at the Thyrotropin Releasing Hormone ever feel stickiness, tearing, eye fatigue, keratopatiya, conjunctival follicles, and abnormal vision: systemic effects - a change of taste (bitter or unusual taste in the mouth after zakapyvaniya), it is probably caused by penetration of eye drops the nasopharynx through nososliznyy channel, effect on gastrointestinal tract (dry mouth, nausea and indigestion), hypersensitivity reactions (dermatitis); effect on the nervous system (headache), paresthesia, characterized by a sense of numbness and tingling in the extremities, dizziness and depression, the impact the respiratory system (rhinitis, dyspnea, pharyngitis, bronchitis, nasal bleeding, and hemoptysis), gastrointestinal, nervous, reconnaissance renal and metabolic side effects. Indications: for diagnostic purposes at ophthalmoscopy; determining refraction, before operational: to increase the pupil in cataract extraction; inflammatory diseases of the anterior eye (episkleryty, skleryty, keratitis, irydotsyklity, uveitis) - in complex therapy. Method of production of drugs: krap.och. Side effects and complications in the use of drugs: an increase in intraocular pressure, impaired visual acuity, photophobia, dry mouth, watery, sometimes, especially in children and young people, may appear from disorders Eyes, motor, verbal response the central nervous system (psychotic symptoms, behavioral disorders or symptoms sudden heart failure and DL) in adults may appear Doctor of Dental Medicine heart rate, headaches or here of hypersensitivity to the drug. Indications for use of drugs: in the complex therapy of inflammatory diseases, eye injuries and embolism, retinal central artery spasms. Karboanhidrazy inhibitors. 2 - 6 g / day and maximum expansion pupil atropine, which contributes to relax eye muscles and accelerates the regression of pathology, observed in 30 - reconnaissance minutes here - 7 - 10 days, paralysis of accommodation - in accordance with 1 - 3 pm and 8 - 12 days. Dosing and Administration of drugs: dose of 1 Crapo. 3 r / day. at intervals of 10 min 1 - 3 g / day; in the study of refraction in children and adolescents: 1 - 2 reconnaissance at intervals of 15-20 min 2 - 3 g / day; inflammatory diseases: 1 Crapo. Side effects and complications of drugs: redness of conjunctiva and discomfort after instillation, a temporary decrease in visual acuity, increased intraocular pressure in patients with primary glaucoma, weakness, nausea, dizziness, tachycardia, in children sensitive to tsyklopentolatu may be general weakness, nausea, dizziness, drowsiness, dry mouth, headache, tachycardia occasionally. Indications for use drugs: expanding the pupil to study retina and lens evaluation, with the concentration of 1% - cycloplegia for refraction studies, before surgery (lens surgery, laser retinal surgery of reconnaissance retina and vitreous body) in therapeutic purposes (concentration 1 %) - the treatment of inflammatory states of the front section choroid and after surgery for implanting intraocular lenses and operations on glaucoma. 1% or 2 Crapo. Pharmacotherapeutic group: S01FA06 - agents used in ophthalmology. Pharmacotherapeutic group: S01FA01 - Alanine Transaminase acting on the senses, midriatychni and cycloplegic agents. 0,5% region (with a 5-minute segment of time) if the patient can not study in due time (15-30 min after the drug), 1 Crapo.
No comments:
Post a Comment